MA03.05 BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
Year: 2019
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: M. Negrao, F. Skoulidis, M. Montesion, K. Schulze, I. Bara, V. Shen, S. Hu, Y. Elamin, X. Le, M. Goldberg, C. Wu, J. Zhang, D. Barreto, W. Rinsurongkawong, G. Simon, J. Roth, S. Swisher, J. Lee, A. Tsao, V. Papadimitrakopoulou, D. Gibbons, B. Glisson, V. Miller, B. Alexander, G. Frampton, L. Albacker, D. Shames, J. Zhang, J. Heymach
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2981957244